(15.07.2021)

Scientists from Oxford and Switzerland, writing in journal Nature, say T-cell protection is a “key feature” of adenovirus vaccines like the Oxford and J&J jabs.

Researcher Prof Burkhard Ludewig, of Cantonal Hospital in Switzerland, said: „The T-cells that come from these cellular training camps appear to have a very high level of ‘fitness’.

“Adenoviruses have co-evolved with humans over a very long time, and learned a lot about the human immune system in the process.